Transcriptional Regulation of the Melanoma Prognostic Marker Melastatin (TRPM1) by MITF in Melanocytes and Melanoma

Cancer Research

Volumn 64, Issue 2, 2004, Pages 509-516

  Miller, Arlo J ^a   Du, Jinyan ^a   Rowan, Sheldon ^b   Hershey, Christine L ^a   Widlund, Hans R ^a   Fisher, David E ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MARKER; MELAN A; MELASTATIN; MESSENGER RNA; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CELL DIFFERENTIATION; CONSENSUS SEQUENCE; CONTROLLED STUDY; EMBRYO; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MELANOCYTE; MELANOMA; METASTASIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; REPORTER GENE; TRANSCRIPTION REGULATION;

ANIMALS; BINDING SITES; CELL LINE, TUMOR; CHROMATIN; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MELANOCYTES; MELANOMA; MEMBRANE PROTEINS; MICE; MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR; NEOPLASM PROTEINS; PROGNOSIS; PROMOTER REGIONS (GENETICS); TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRPM CATION CHANNELS;

EID: 1642515793     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-03-2440     Document Type: Article

References (39)

1. ACS Cancer Facts & Figures 2002. Atlanta, GA: American Cancer Society, Inc., 2003.
2. Rigel, D. S., Friedman, R. J., and Kopf, A. W. Lifetime risk for development of skin cancer in the U. S. population: current estimate is now 1 in 5. J. Am. Acad. Dermatol., 35: 1012-1013, 1996.
3. Breslow, A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann. Surg., 172: 902-908, 1970.
4. Duncan, L. M., Deeds, J., Hunter, J., Shao, J., Holmgren, L. M., Woolf, E. A., Tepper, R. I., and Shyjan, A. W. Down-regulation of the novel gene melastatin correlates with potential for melanoma metastasis. Cancer Res., 58: 1515-1520, 1998.
5. Deeds, J., Cronin, F., and Duncan, L. M. Patterns of melastatin mRNA expression in melanocytic tumors. Hum. Pathol., 31: 1346-1356, 2000.
6. Duncan, L. M., Deeds, J., Cronin, F. E., Donovan, M., Sober, A. J., Kauffman, M., and McCarthy, J. J. Melastatin expression and prognosis in cutaneous malignant melanoma. J. Clin. Oncol., 19: 568-576, 2001.
7. Selzer, E., Wacheck, V., Lucas, T., Heere-Ress, E., Wu, M., Weilbaecher, K. N., Schlegel, W., Valent, P., Wrba, F., Pehamberger, H., Fisher, D., and Jansen, B. The melanocyte-specific isoform of the microphthalmia transcription factor affects the phenotype of human melanoma. Cancer Res., 62: 2098-2103, 2002.
8. Seiter, S., Monsurro, V., Nielsen, M. B., Wang, E., Provenzano, M., Wunderlich, J. R., Rosenberg, S. A., and Marincola, F. M. Frequency of MART-1/MelanA and gp100/PMel17-specific T cells in tumor metastases and cultured tumor-infiltrating lymphocytes. J. Immunother., 25: 252-263, 2002.
9. Holbauer, G. F., Kamarashev, J., Geertsen, R., Boni, R., and Dummer, R. Melan A/MART-1 immunoreactivity in formalin-fixed paraffin-embedded primary and metastatic melanoma: frequency and distribution. Melanoma Res., 8: 337-343, 1998.
10. Salti, G. I., Manougian, T., Farolan, M., Shilkaitis, A., Majumdar, D., and Das Gupta, T. K. Microphthalmia transcription factor: a new prognostic marker in intermediate-thickness cutaneous malignant melanoma. Cancer Res., 60: 5012-5016, 2000.
11. Takeuchi, H., Kuo, C., Morton, D. L., Wang, H. J., and Hoon, D. S. Expression of differentiation melanoma-associated antigen genes is associated with favorable disease outcome in advanced-stage melanomas. Cancer Res., 63: 441-448, 2003.
12. King, R., Weitbaecher, K. N., McGill, G., Cooley, E., Mihm, M., and Fisher, D. E. Microphthalmia transcription factor. A sensitive and specific melanocyte marker for melanoma diagnosis. Am. J. Pathol., 155: 731-738, 1999.
13. Hodgkinson, C. A., Moore, K. J., Nakayama, A., Steingrimsson, E., Copeland, N. G., Jenkins, N. A., and Amheiter, H. Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loop-helix-zipper protein. Cell, 74: 395-404, 1993.
14. Miettinen, M., Fernandez, M., Franssila, K., Gatalica, Z., Lasota, J., and Sarlomo-Rikala, M. Microphthalmia transcription factor in the immunohistochemical diagnosis of metastatic melanoma: comparison with four other melanoma markers. Am. J. Surg. Pathol., 25: 205-211, 2001.
15. Granter, S. R., Weilbaecher, K. N., Quigley, C., and Fisher, D. E. Role for microphthalmia transcription factor in the diagnosis of metastatic malignant melanoma. Appl. Immunohistochem. Mol. Morphol., 10: 47-51, 2002.
16. Bentley, N. J., Eisen, T., and Goding, C. R. Melanocyte-specific expression of the human tyrosinase promoter: activation by the microphthalmia gene product and role of the initiator. Mol. Cell. Biol., 14: 7996-8006, 1994.
17. Hemesath, T. J., Steingrimsson, E., McGill, G., Hansen, M. J., Vaught, J., Hodgkinson, C. A., Arnheiter, H., Copeland, N. G., Jenkins, N. A., and Fisher, D. E. Microphthalmia, a critical factor in melanocyte development, defines a discrete transcription factor family. Genes Dev., 8: 2770-2780, 1994.
18. Yasumoto, K., Yokoyama, K., Shibata, K., Tomita, Y., and Shibahara, S. Microphthalmia-associated transcription factor as a regulator for melanocyte-specific transcription of the human tyrosinase gene. Mol. Cell. Biol., 14: 8058-8070, 1994.
19. Du, J., Miller, A. J., Widlund, H. R., Horstmann, M. A., Ramaswamy, S., and Fisher, D. E. MLANA/MART1 and SILV/PMEL17/GP100 are transcriptionally regulated by MITF in melanocytes and melanoma. Am. J. Pathol., 163: 333-343, 2003.
20. Lerner, A. B., Shiohara, T., Boissy, R. E., Jacobson, K. A., Lamoreux, M. L., and Moellmann, G. E. A mouse model for vitiligo. J. Investig. Dermatol., 87: 299-304, 1986.
21. Steingrimsson, E., Moore, K. J., Lamoreux, M. L., Ferre-D'Amare, A. R., Burley, S. K., Zimring, D. C., Skow, L. C., Hodgkinson, C. A., Arnheiter, H.; Copeland, N. G., and et al. Molecular basis of mouse microphthalmia (mi) mutations helps explain their developmental and phenotypic consequences. Nat. Genet., 8: 256-263, 1994.
22. Price, E. R., and Fisher, D. E. Sensorineural deafness and pigmentation genes: melanocytes and the Mitf transcriptional network. Neuron, 30: 15-18, 2001.
23. Tachibana, M., Perez-Jurado, L. A., Nakayama, A., Hodgkinson, C. A., Li, X., Schneider, M., Miki, T., Fex, J., Francke, U., and Arnheiter, H. Cloning of MITF, the human homolog of the mouse microphthalmia gene and assignment to chromosome 3p14.1-p12.3. Hum. Mol. Genet., 3: 553-557, 1994.
24. Hunter, J. J., Shao, J., Smutko, J. S., Dussault, B. J., Nagle, D. L., Woolf, E. A., Holmgren, L. M., Moore, K. J., and Shyjan, A. W. Chromosomal localization and genomic characterization of the mouse melastatin gene (Mlsn1). Genomics, 54: 116-123, 1998.
25. McGill, G. G., Horstmann, M., Widlund, H. R., Du, J., Motyckova, G., Nishimura, E. K., Lin, Y. L., Ramaswamy, S., Avery, W., Ding, H. F., Jordan, S. A., Jackson, I. J., Korsmeyer, S. J., Golub, T. R., and Fisher, D. E. Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability. Cell, 109: 707-718, 2002.
26. Wu, M., Hemesath, T. J., Takemoto, C. M., Horstmann, M. A., Wells, A. G., Price, E. R., Fisher, D. Z., and Fisher, D. E. c-Kit triggers dual phosphorylations, which couple activation and degradation of the essential melanocyte factor Mi. Genes Dev., 14: 301-312, 2000.
27. Widlund, H. R., Horstmann, M. A., Price, E. R., Cui, J., Lessnick, S. L., Wu, M., He, X., and Fisher, D. E. â-catenin-induced melanoma growth requires the downstream target microphthalmia-associated transcription factor. J. Cell Biol., 158: 1079-1087, 2002.
28. He, T. C., Zhou, S., da Costa, L. T., Yu, J., Kinzler, K. W., and Vogelstein, B. A simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sci. USA, 95: 2509-2514, 1998.
29. Murtaugh, L. C., Chyung, J. H., and Lassar, A. B. Sonic hedgehog promotes somitic chondrogenesis by altering the cellular response to BMP signaling. Genes Dev., 13: 225-237, 1999.
30. Nakayama, A., Nguyen, M. T., Chen, C. C., Opdecamp, K., Hodgkinson, C. A., and Arnheiter, H. Mutations in microphthalmia, the mouse homolog of the human deafness gene MITF, affect neuroepithelial and neural crest-derived melanocytes differently. Mech. Dev., 70: 155-166, 1998.
31. Fuse, N., Yasumoto, K., Takeda, K., Amae, S., Yoshizawa, M., Udono, T., Takahashi, K., Tamai, M., Tomita, Y., Tachibana, M., and Shibahara, S. Molecular cloning of cDNA encoding a novel microphthalmia-associated transcription factor isoform with a distinct amino-terminus. J. Biochem. (Tokyo), 126: 1043-1051, 1999.
32. Ellerhorst, J. A., Prieto, V. G., Ekmekcioglu, S., Broemeling, L., Yekell, S., Chada, S., and Grimm, E. A. Loss of MDA-7 expression with progression of melanoma. J. Clin. Oncol., 20: 1069-1074, 2002.
33. Kageshita, T., Hamby, C. V., Ishihara, T., Matsumoto, K., Saida, T., and Ono, T. Loss of â-catenin expression associated with disease progression in malignant melanoma. Br. J. Dermatol., 145: 210-216, 2001.
34. Steingrimsson, E., Nii, A., Fisher, D. E., Ferre-D'Amare, A. R., McCormick, R. J., Russell, L. B., Burley, S. K., Ward, J. M., Jenkins. N. A., and Copeland, N. G. The semidominant Mi(b) mutation identifies a role for the HLH domain in DNA binding in addition to its role in protein dimerization. EMBO J., 15: 6280-6289, 1996.
35. Fang, D., and Setaluri, V. Expression and up-regulation of alternatively spliced transcripts of melastatin, a melanoma metastasis-related gene, in human melanoma cells. Biochem. Biophys. Res. Commun., 279: 53-61, 2000.
36. Halaban, R., Cheng, E., Zhang, Y., Moellmann, G., Hanlon, D., Michalak, M., Setaluri, V., and Hebert, D. N. Aberrant retention of tyrosinase in the endoplasmic reticulum mediates accelerated degradation of the enzyme and contributes to the dedifferentiated phenotype of amelanotic melanoma cells. Proc. Natl. Acad. Sci. USA, 94: 6210-6215, 1997.
37. Price, E. R., Horstmann, M. A., Wells, A. G., Weilbaecher, K. N., Takemoto, C. M., Landis, M. W., and Fisher, D. E. á -Melanocyte-stimulating hormone signaling regulates expression of microphthalmia, a gene deficient in Waardenburg syndrome. J. Biol. Chem., 273: 33042-33047, 1998.
38. Bertolotto, C., Abbe, P., Hemesath, T. J., Bille, K., Fisher, D. E., Ortonne, J. P., and Ballotti, R. Microphthalmia gene product as a signal transducer in cAMP-induced differentiation of melanocytes. J. Cell Biol., 142: 827-835, 1998.
39. Busca, R., and Ballotti, R. Cyclic AMP a key messenger in the regulation of skin pigmentation. Pigment Cell Res., 13: 60-69, 2000.